Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Cash from Financing Activities (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Cash from Financing Activities data on record, last reported at $45.7 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 20487.39% to $45.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $256.8 million, a 1.32% decrease, with the full-year FY2025 number at $211.3 million, down 21.4% from a year prior.
  • Cash from Financing Activities reached $45.7 million in Q1 2026 per OLMA's latest filing, down from $213.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for OLMA hit a ceiling of $244.3 million in Q4 2024 and a floor of -$2.5 million in Q2 2025.
  • A 5-year average of $38.8 million and a median of $273000.0 in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: soared 123134.91% in 2023, then plummeted 116.14% in 2025.
  • Tracing OLMA's Cash from Financing Activities over 5 years: stood at $273000.0 in 2022, then soared by 91.58% to $523000.0 in 2023, then surged by 46611.28% to $244.3 million in 2024, then dropped by 12.59% to $213.6 million in 2025, then plummeted by 78.6% to $45.7 million in 2026.
  • Business Quant data shows Cash from Financing Activities for OLMA at $45.7 million in Q1 2026, $213.6 million in Q4 2025, and $41000.0 in Q3 2025.